Chalk Talk: Mediar TherapeuticsApril 28, 2021
Time: 3 PM - 3:45 PM
It's time again to hear from one of our resident companies and learn what's going on inside their lab! Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis. The platform and pipeline are based on an emerging class of novel targets – fibrotic mediators – that play key roles in modulating myofibroblast biology and the development of fibrosis in chronically damaged organs.
This will be hosted via Zoom, and registration is required. Register now to get insight into Mediar's technology and ask your burning questions! A lunch voucher will be provided to all who register by April 22.